These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9663654

  • 21. In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications.
    Kalogeras KT, Calogero AE, Kuribayiashi T, Khan I, Gallucci WT, Kling MA, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1990 May; 70(5):1462-71. PubMed ID: 2159487
    [Abstract] [Full Text] [Related]

  • 22. Hypoglycemia-induced inhibition of LH and stimulation of ACTH secretion in the rhesus monkey is blocked by alprazolam.
    Van Vugt DA, Washburn DL, Farley AE, Reid RL.
    Neuroendocrinology; 1997 May; 65(5):344-52. PubMed ID: 9158066
    [Abstract] [Full Text] [Related]

  • 23. Effects of dehydroepiandrosterone and alprazolam on hypothalamic-pituitary responses to exercise.
    Deuster PA, Faraday MM, Chrousos GP, Poth MA.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4777-83. PubMed ID: 15928250
    [Abstract] [Full Text] [Related]

  • 24. Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.
    Inder WJ, Hellemans J, Ellis MJ, Evans MJ, Livesey JH, Donald RA.
    J Clin Endocrinol Metab; 1995 Jan; 80(1):244-8. PubMed ID: 7829620
    [Abstract] [Full Text] [Related]

  • 25. A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotropin-releasing hormone.
    Hockings GI, Grice JE, Walters MM, Crosbie GV, Torpy DJ, Jackson RV.
    Neuroendocrinology; 1995 Feb; 61(2):198-206. PubMed ID: 7753339
    [Abstract] [Full Text] [Related]

  • 26. Potentiation of fenfluramine-induced ACTH release in man by naloxone.
    Jackson RV, Grice JE, Jackson AJ, Vella RD.
    Clin Exp Pharmacol Physiol; 1989 Apr; 16(4):263-7. PubMed ID: 2545393
    [Abstract] [Full Text] [Related]

  • 27. The effect of naloxone on adrenocorticotropin and cortisol release: evidence for a reduced response in depression.
    Burnett FE, Scott LV, Weaver MG, Medbak SH, Dinan TG.
    J Affect Disord; 1999 Jun; 53(3):263-8. PubMed ID: 10404712
    [Abstract] [Full Text] [Related]

  • 28. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
    Scott LV, Dinan TG.
    Life Sci; 1998 Jun; 62(22):1985-98. PubMed ID: 9627097
    [Abstract] [Full Text] [Related]

  • 29. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.
    Alexander SL, Irvine CH, Donald RA.
    Front Neuroendocrinol; 1996 Jan; 17(1):1-50. PubMed ID: 8788568
    [Abstract] [Full Text] [Related]

  • 30. L-type calcium channels and CRH-mediated ACTH and cortisol release in humans.
    Hockings GI, Grice JE, Walters MM, Jackson RV.
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):303-7. PubMed ID: 1648460
    [Abstract] [Full Text] [Related]

  • 31. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI, Grice JE, Crosbie GV, Walters MM, Jackson AJ, Jackson RV.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [Abstract] [Full Text] [Related]

  • 32. Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive compulsive disorder, and healthy controls.
    Michelson D, Altemus M, Galliven E, Hill L, Greenberg BD, Gold P.
    Neuropsychopharmacology; 1996 Aug; 15(2):207-12. PubMed ID: 8840357
    [Abstract] [Full Text] [Related]

  • 33. New diagnostic tests for Cushing's syndrome: uses of naloxone, vasopressin and alprazolam.
    Jackson RV, Hockings GI, Torpy DJ, Grice JE, Crosbie GV, Walters MM, Strakosch CR.
    Clin Exp Pharmacol Physiol; 1996 Aug; 23(6-7):579-81. PubMed ID: 8800590
    [Abstract] [Full Text] [Related]

  • 34. Brain beta-endorphin and other opioids are involved in restraint stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat.
    Yamauchi N, Shibasaki T, Wakabayashi I, Demura H.
    Brain Res; 1997 Nov 28; 777(1-2):140-6. PubMed ID: 9449422
    [Abstract] [Full Text] [Related]

  • 35. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug 28; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

  • 36. Differential effects of naloxone on basal and stress-induced release of ACTH and prolactin in the male rat.
    Xu RK, McCann SM.
    Life Sci; 1989 Aug 28; 45(17):1591-9. PubMed ID: 2555640
    [Abstract] [Full Text] [Related]

  • 37. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.
    Scott LV, Burnett F, Medbak S, Dinan TG.
    Psychol Med; 1998 Mar 28; 28(2):285-93. PubMed ID: 9572086
    [Abstract] [Full Text] [Related]

  • 38. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A, Guido M, Ciampelli M, Fulghesu AM, Pavone V, Proto C, Caruso A, Mancuso S.
    Clin Endocrinol (Oxf); 1996 Jul 28; 45(1):73-7. PubMed ID: 8796141
    [Abstract] [Full Text] [Related]

  • 39. Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ, Jackson RV, Grice JE, Hockings GI, Crosbie GV, Walters MM.
    Clin Exp Pharmacol Physiol; 1994 Feb 28; 21(2):157-61. PubMed ID: 8039271
    [Abstract] [Full Text] [Related]

  • 40. [Glucocorticoid hypofunction in myotonic dystrophy].
    Forga L, Anda E, Basterra FJ, Goñi MJ, Pineda FJ.
    An Sist Sanit Navar; 2007 Feb 28; 30(2):199-205. PubMed ID: 17898815
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.